Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy
Frontiers in Immunology · 2023
DOI: 10.3389/fimmu.2023.1228331 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, 2023. Verfasst von Yue Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer immunotherapy has exhibited promising antitumor effects in various tumors. Infiltrated regulatory T cells (Tregs) in the tumor microenvironment (TME) restrict protective immune surveillance, impede effective antitumor immune responses, and contribute to the formation of an immunosuppressive microenvironment. Selective depletion or functional attenuation of tumor-infiltrating Tregs, while eliciting effective T-cell responses, represents a potential approach for anti-tumor immunity. Furthermore, it does not disrupt the Treg-dependent immune homeostasis in healthy organs and does not induce autoimmunity. Yet, the shared cell surface molecules and signaling pathways between Tregs and multiple immune cell types pose challenges in this process. Noncoding RNAs (ncRNAs), including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), regulate both cancer and immune cells and thus can potentially improve antitumor responses. Here, we review recent advances in research of tumor-infiltrating Tregs, with a focus on the functional roles of immune checkpoint and inhibitory Tregs receptors and the regulatory mechanisms of ncRNAs in Treg plasticity and functionality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang, Liaoning, China.
- Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
- Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
- Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
- Medical Oncology Department of Gastrointestinal Cancer, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang, Liaoning, China.
Zitieren
APA
Ma, Y., Xu, X., Wang, H., Liu, Y., & Piao, H. (2023). Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1228331
Vancouver
Ma Y, Xu X, Wang H, Liu Y, Piao H. Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy. Frontiers in Immunology. 2023. doi:10.3389/fimmu.2023.1228331
BibTeX
@article{Ma2023,
author = {Ma, Yue and Xu, Xin and Wang, Huaitao and Liu, Yang and Piao, Haiyan},
title = {Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy},
journal = {Frontiers in Immunology},
year = {2023},
doi = {10.3389/fimmu.2023.1228331}
}
EUVIMED